The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
Randomized, open-label, multicenter study to compare the efficacy and safety of Combination
of High-dose Dexamethasone and Tacrolimus versus High-dose Dexamethasone for the first-line
treatment of adults with primary immune thrombocytopenia (ITP).
Phase:
Phase 2
Details
Lead Sponsor:
Peking University People's Hospital
Collaborators:
Beijing Friendship Hospital Beijing Hospital China-Japan Friendship Hospital First Affiliated Hospital of Chongqing Medical University Shanxi Bethune Hospital The First Affiliated Hospital of Zhengzhou University